Seller record · Research vendor

Pinnacle Peptides

By Peptide Alliance, Editorial publisherRecorded September 2026 · Standard v1.1 · How checks are performed

Fails 5 of 8 criteria. S1, prescriber requirement: No clinician evaluation is claimed anywhere on the site, and every product page carries a research-use-only notice. 4 more criteria also fail; see the table below.

At a glance

Pinnacle PeptidesResearch vendor

3/8criteria passed

Price: Printed on its own pages before sign-up
Sells: research peptides including semaglutide, tirzepatide, BPC-157 and ipamorelin, and 4 more
FDA letters: 1 on file

Visit Pinnacle Peptides See all eight dispositions

Research vendor. Passes 3 of 8 criteria. Recorded against Standard v1.1.

A research peptide and chemical seller trading since 2010, offering peptides, GLP-1 analogues and research liquids. The only postal address it publishes is in Panama, and an FDA letter addressed to it prints a North Carolina street address instead.

Operating entity No legal entity name is printed in the footer, the contact page, the customer-service page or the privacy policy.

Dispositions

Code	Criterion	Disposition	Where it appears
S1	Prescriber requirement	FAIL	Pinnacle Peptides' FAQ
S2	Prescription gating	FAIL	Pinnacle Peptides' cart
S3	Pharmacy identification	FAIL	Pinnacle Peptides' FAQ
S4	Compounding disclosure	PASS	Pinnacle Peptides' research company page
S5	Analytical documentation	FAIL	Pinnacle Peptides' FAQ
S6	Business address	FAIL	Pinnacle Peptides' contact page
S7	Price disclosure	PASS	Pinnacle Peptides' buy ipamorelin page
S8	Enforcement status	PASS	FDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1FAILNo clinician evaluation is claimed anywhere on the site, and every product page carries a research-use-only notice.Source: Pinnacle Peptides' FAQ.

S2FAILA cart carries the item and no screen asks an eligibility question, starting from the ipamorelin page at 34.99 dollars.Source: Pinnacle Peptides' cart.

S3FAILNo pharmacy is named anywhere on the site, and a footer notice states that the seller is not a compounding pharmacy under section 503A.Source: Pinnacle Peptides' FAQ.

S4PASSThe seller offers no compounded drug, the words compounded and compounding appear nowhere on the site, and a footer notice disclaims any compounding role.Source: Pinnacle Peptides' research company page.

S5FAILThe questions page explains how purity is measured and guarantees above 99 percent, and no certificate, chromatogram or lot report is reachable from any page on the site.Source: Pinnacle Peptides' FAQ.

S6FAILThe only postal address printed on the site is a mailing address in Panama City, Panama, and no United States address appears anywhere.Source: Pinnacle Peptides' contact page.

S7PASSThe ipamorelin page prints 34.99 dollars for one 5 mg vial with quantity tiers falling to 24.49 dollars, visible with no account.Source: Pinnacle Peptides' buy ipamorelin page.

S8PASSFDA warning letter 719337, December 2025, names Pinnacle Professional Research doing business as Pinnacle Peptides and alleges its products marketed as selective androgen receptor modulators are unapproved new drugs. No FDA action has halted the business, and the seller still trades.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: research peptides including semaglutide, tirzepatide, BPC-157 and ipamorelin, peptide blends, research liquids, selective androgen receptor modulators, diluents.

Other sellers of the same products

Who sells semaglutide Who sells tirzepatide Who sells BPC-157 Who sells ipamorelin

Enforcement documents on file: 1 warning letter

FDA warning letter 719337, issued December 2025, to Pinnacle Professional Research dba Pinnacle PeptidesThe products marketed as selective androgen receptor modulators on Pinnacle Peptides' website are unapproved new drugs intended for human use, despite research-only labeling.

A warning letter alleges violations and requests a response. It does not halt a business, and it does not remove a seller from this ledger. Every letter recorded here.

Visit Pinnacle Peptides

535 sellers pass S1, prescriber requirement

See all 535 on the S1 criterion page — 527 more than shown here.

This seller fails criteria a medical service must meet. The records above belong to sellers that pass S1; some are partner links, disclosed on their records.

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.